HPS GROUP (ON BEHALF OF RARE DISEASE THERAPEUTICS)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2013

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2013	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
PETERSON GROUP (FL)	—	3

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	2
HOUSE OF REPRESENTATIVES	2
Health & Human Services, Dept of (HHS)	2
SENATE	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	3

HPS GROUP (ON BEHALF OF RARE DISEASE THERAPEUTICS) — Lobbying Disclosure | Poliscope